Provision Language
<p><span style=”text–decoration: underline;”><strong>9. COSTS AND EXPENSES; PAYMENTSstrong>span>p>
<p>Except as otherwise specified in this Agreement or in a Research Plan, each Party shall be solely responsible for all of its own costs and expenses associated with the performance of its activities under the Research Plan including, without limitation, expenses related to the attendance of its representatives at <a href=”https://ghiaa.org/provision_document/dndi–template–research–collaboration–and–license–agreement/” target=”_blank” rel=”noopener“>JRCa> meetings, and neither Party shall make any payment or pay any financial contribution to the other Party in consideration of the other Party’s performance under this Agreement.p>
<p><span style=”text–decoration: underline;”><strong>14. GRANT OF LICENSE RIGHTSstrong>span>p>
<p>[…]p>
<p><strong>14.4strong> Effective at such time as Partner elects to become the Development Partner and a Development Agreement is executed between the Parties, DNDi hereby grants to Partner, to the extent that it is able, in addition to the licenses granted under <a href=”https://ghiaa.org/provision_document/dndi–template–research–collaboration–and–license–agreement–14/” target=”_blank” rel=”noopener“>Section 14.2a>, a nonexclusive, worldwide, perpetual, irrevocable license, with the right to sublicense under DNDi’s rights to and interests in DNDi Background Technology and DNDi Collaboration Technology to commercialize the Product in the Field outside of the Territory at a price to be determined by Partner that allows a purchaser in a particular sector to buy such Product in sufficient quantities to meet its public health or individual needs. In consideration of the license grants outside the Territory, Partner shall compensate DNDi, such amount of compensation to be mutually agreed upon by the Parties based on good faith negotiations. It is DNDi’s intent to invest any such compensation in access to medicines programs.p>
